medigraphic.com
ISSN 1729-519X (Print)

2020, Number 3

<< Back Next >>

Revista Habanera de Ciencias Médicas 2020; 19 (3)

COVID-19. From pathogenesis to high mortality in elderly patients with comorbidities

Serra VMÁ

Language: Spanish
References: 26
Page: 1-12
PDF size: 908.98 Kb.


ABSTRACT

Introduction: Coronavirus disease-2019 (COVID-19) and the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) are causing a pandemic associated with high mortality. Although many uncertainties still remain because it is a new viral infectious disease, knowledge of clinical behavior and pathogenesis has advanced.
Objective: To review the most current scientific evidence on the pathogenesis of the disease and its association with high mortality in elderly patients with comorbidities.
Material and Methods: A literature review of the information published to date on this respect was carried out. Databases such as MEDLINE, LILACS, SCIELO, LATINDEX, MEDIGRAPHIC, MEDSCAPE, Science Direct, Elsevier and PubMed were searched; important data were also obtained from WHO / PAHO bulletins, the Cuban National Health Care Telecommunications Network and Portal (infomed) and other news agencies that present good scientific evidence.
Development: An analysis of the current knowledge about the pathogenesis and the pulmonary inflammatory process is carried out while observing that this process does not respond to a simple viral pneumonia but to a local and systemic inflammatory process that involves different organs, coagulation disorders and alterations of immunity that make elderly patients with comorbidities more vulnerable, causing severity and increasing mortality.
Conclusions: The pathogenesis of this disease, which is better known at present, explains the implications in critical and severe cases with high mortality, especially the most vulnerable ones. SARS and its evolutive complications are not explained by lung inflammation only. Other factors are involved in the well-known pathogenesis of a much greater severity that leads to the fatal outcome.


REFERENCES

  1. Serra Valdés M, Serra Ruiz M, Viera García M. Las enfermedades crónicas no transmisibles: magnitud actual y tendencias futuras. Revista Finlay [Internet]. 2018 [Citado 29/04/2020];8(2):[Aprox. 8 p.]. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/561

  2. Suero LEL, Valencia SEV, Jara GDLM, Quishpe AAC. La mejor evidencia científica, ante la pendemia de SARS-Cov-2. Mediciencias UTA [Internet]. 2020 [Citado 29/04/2020];4(2):3-29. Disponible en: https://medicienciasuta.uta.edu.ec/index.php/MedicienciasUTA/article/download/344/218

  3. Ruiz Bravo A, Jiménez Varela M. SARS-CoV-2 y pandemia de síndrome respiratorio agudo (COVID-19). Ars Pharmaceutica Norteamérica [Internet]. 2020 Abr [Citado 29/04/2020];61:[Aprox. 8 p.]. Disponible en: https://revistaseug.ugr.es/index.php/ars/article/view/15177

  4. Accinelli RA, Xu CMZ, Yachachín Chávez JM, Cáceres Pizarro JA, Tafur Bances KB, Flores Tejada RG, et al. COVID-19: La pandemia por el nuevo virus SARS-CoV-2. Revista Peruana de Medicina Experimental y Salud Pública [Internet]. 2020 [Citado 29/04/2020];37(2):[Aprox. 8 p.]. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/5411

  5. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020 [Citado 29/04/2020];323:[Aprox. 2 p.] Disponible en: https://www.doi.org/10.1001/jama.2020.1585

  6. Centro Nacional de Información de Ciencias Médicas. Infección por Coronavirus. Estadísticas [Internet]. La habana: Centro Nacional de Información de Ciencias Médicas; 2020 [Citado 11/05/2020]. Disponible en: https://temas.sld.cu/coronavirus/covid-19/

  7. Hoffmann M, Kleine Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell [Internet]. 2020 Mar [Citado 23/04/2020];1(81):1-10. Disponible en: https://doi.org/10.1016/j.cell.2020.02.052

  8. Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, Ruggeri A, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis [Internet]. Australia: Critical Care and Resuscitation; 2020 [Citado 29/04/2020]. Disponible en: https://ccr.cicm.org.au/config/cicm-ccr/media/PDF/June-COVID-19/CCR_Landoni120_June_v6.pdf

  9. Mehta D. Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet [Internet]. 2020 Abr [Citado 27/04/2020];395:[Aprox. 2 p.]. Disponible en: https://doi.org/10.1016/S0140-6736(20)30628-0

  10. Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA [Internet]. 2020 [Citado 23/01/2020];323(8):707-8. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2759815

  11. Neha Pathak M. The Great Invader: How COVID-19 Attacks Every Organ [Internet]. New York: Medscape's Coronavirus Resource Center; 2020 [Citado 29/04/2020]. Disponible en: https://www.medscape.com/viewarticle/929284?nlid=135262_3243&src=WNL_mdplsfeat_200428_mscpedit_imed&uac=226682DK&spon=18&uac=226682DK&spon=18&uac=226682DK&spon=18&uac=226682DK&spon=18&uac=226682DK&spon=18&uac=226682DK&sfa=18&imp

  12. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet [Internet]. 2020 Abr [Citado 29/04/2020];395:[Aprox. 2 p.]. Disponible en: https://covid19comisionunam.unamglobal.com/?p=84772&fbclid=IwAR3KippZYIofWxzHA5s3GHuetq9HeXRUVK9ZPqYz8oS-TWYZm6EsC7bGz2w

  13. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost [Internet]. 2020 [Citado 29/04/2020];18:844-7. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14768

  14. Goodman B. Los problemas pulmonares de COVID-19 pueden comenzar en los vasos sanguíneos [Internet]. New York: Medscape; 2020 [Citado 29/04/2020]. Disponible en: https://www.medscape.com/viewarticle/929496

  15. Davenport L. Neumonía por COVID-19: solo algunos casos son parecidos al síndrome de insuficiencia respiratoria aguda grave [Internet]. New York: Medscape; 2020 [Citado 08/05/2020]. Disponible en: https://espanol.medscape.com/verarticulo/5905390?src=mkm_latmkt_200508_mscmrk_escoronavirus_nl&uac=226682DK&impID=2373286&faf=1

  16. Nieto Martínez C. Mayor vulnerabilidad y sintomatología atípica en pacientes mayores con COVID- 19. Medscape [Internet]. New York: Medscape; 2020. [Citado 05/05/2020]. Disponible en: https://espanol.medscape.com/verarticulo/5905380

  17. Megan Brooks M. Datos más sólidos de lesión miocárdica en COVID-19 [Internet]. New York: Medscape's Coronavirus Resource Center; 2020 [Citado 29/04/2020]. Disponible en: https://espanol.medscape.com/verarticulo/5905339?src=mkm_latmkt_200429_mscmrk_escoronavirus_nl&uac=226682DK&impID=2362787&faf=1

  18. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q. et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. International Journal of Infectious Diseases [Internet]. 2020 [Citado 23/03/2020];91:[Apox. 2 p.]. Disponible en: https://doi.org/10.1016/j.ijid.2020.03.017

  19. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Journal [Internet]. 2020 [Citado 29/04/2020];29:[Aprox. 2 p.]. Disponible en: https://doi.org/10.1101/2020.02.22.20026500

  20. Meziani F. Neurologic Features in Severe SARS-CoV-2 Infection. NEJM [Internet] 2020 Apr [Citado 29/04/2020];382:[Aprox. 2 p.]. Disponible en: https://www.nejm.org/doi/full/10.1056/NEJMc2008597?query=featured_home %E2 %80 %A6+ %40NEJM

  21. Huang I, Lim MA, Pranata R. La diabetes mellitus se asocia con una mayor mortalidad y gravedad de la enfermedad en la neumonía por COVID-19: una revisión sistemática, un metanálisis y una metarregresión. Diabetes Metab Syndr [Internet]. 2020 Abr [Citado 27/04/2020];14(4):[aprox. 22 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162793/

  22. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. La diabetes es un factor de riesgo para la progresión y el pronóstico de COVID-19. Diabetes Metab Res Rev [Internet]. 2020 Mar [Citado 27/04/2020];36:[Aprox. 25 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/dmrr.3319

  23. Liang W, Guan W, Chen R. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol [Internet]. 2020 Feb [Citado 29/04/2020];21:[Aprox. 2 p.]. Disponible en: http://doi.org/10.1016/S1470-2045(20)30096-6

  24. Aakash D, Sonali S, Tarang Pa, Rupak D. COVID-19 and Cancer: Lessons From a Pooled Meta-Analysis. JCO Global Oncology [Internet]. 2020 [Citado 29/04/2020];6:557-9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/32250659

  25. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov [Internet]. New York: MedRxiv; 2020 [Citado 29/04/2020]. Disponible en: https://www.medrxiv.org/content/medrxiv/early/2020/02/17/2020.02.05.20020107.full.pdf

  26. Qifang B, Yongsheng W, Shujiang M, Chenfei Y, Xuan Z, Zhen Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis [Internet]. 2020 Apr [Citado 10/05/2020];20:[Aprox. 2p.]. Disponible en: https://doi.org/10.1016/S1473-3099(20)30287-5




2020     |     www.medigraphic.com